The Roche Elecsys® CA 125 II assay is a tumor marker test for use with blood samples to support monitoring and surveillance of ovarian cancer patients and together with Elecsys® HE4 for risk assessment of patients with pelvic mass with the ROMA™ algorithm
- CA 125 is found in a high percentage of ovarian tumors of epithelial origin1-2
- CA 125 is widely mentioned in international guidelines for use in pelvic mass evaluation and in therapy and recurrence monitoring of ovarian cancer3-5
- In addition, HE4 complements CA 125 in identifying patients with disease recurrence and disease progression9-11